CagAcoprotein:

N Varshney1, D Kashyap1, S K Behra2

  • 1Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, India.

概括

经FDA批准的抗生素显示出对CagA阳性Helicobacter pylori的组合治疗的潜力. 这些药物有效地与CagA蛋白结合,为抗击H. pylori感染和降低胃癌风险提供了一种新的策略.